Xifaxanta
Xifaxanta
- In our pharmacy, you can buy xifaxanta without a prescription, with delivery in 5–14 days throughout United Kingdom. Discreet and anonymous packaging.
- Xifaxanta (rifaximin) is used for travellers’ diarrhoea caused by E. coli, for symptomatic treatment of IBS‑D (irritable bowel syndrome with diarrhoea), and to prevent or treat hepatic encephalopathy; it is a non‑absorbable rifamycin antibiotic that inhibits bacterial RNA synthesis by binding to the beta subunit of DNA‑dependent RNA polymerase, acting locally in the gut.
- Usual adult doses are: travellers’ diarrhoea 200 mg orally three times daily for 3 days; IBS‑D 550 mg orally three times daily for 14 days; hepatic encephalopathy 550 mg orally twice daily for ongoing management. Paediatric dosing is generally not established below 12 years (≥12 years may use adult regimens for certain indications).
- Administration is oral: tablets (commonly 200 mg and 550 mg) and, in some markets, an oral suspension (100 mg/5 mL).
- Onset: relief of diarrhoea is often seen within 24–72 hours for travellers’ diarrhoea; for IBS‑D some patients notice improvement within days, though full symptomatic benefit is usually assessed over the two‑week course.
- Duration of action depends on the indication and regimen: travellers’ diarrhoea treatment is a 3‑day course; IBS‑D is a 2‑week course with benefits that may persist for weeks in some patients; hepatic encephalopathy typically requires chronic, continuous therapy to maintain effect.
- Alcohol warning: there is no specific disulfiram‑like interaction with rifaximin, but avoid alcohol if you have hepatic impairment or hepatic encephalopathy as alcohol can worsen liver disease and neurocognitive symptoms; alcohol may also aggravate diarrhoea.
- The most common side effect is nausea; other frequent adverse effects include constipation, abdominal pain, flatulence and headache, with rare hypersensitivity reactions.
- Would you like to try xifaxanta without a prescription?
Xifaxanta
Basic Xifaxanta Information
- INN (International Nonproprietary Name): Rifaximin
- Brand Names Available In United Kingdom: not specified
- ATC Code: A07AA11
- Forms & Dosages: Oral tablet 200mg and 550mg; oral suspension 100mg/5mL (oral suspension not available in all regions)
- Manufacturers In United Kingdom: not specified
- Registration Status In United Kingdom: not specified
- OTC / Rx Classification: Prescription-only (Rx)
Critical Warnings & Restrictions
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Patients worry about safety more than efficacy when they are elderly, pregnant or have chronic disease.
Confirm whether the patient has a valid prescription before supplying or advising about xifaxanta.
Ask about allergy history, especially to rifamycins such as rifampicin or rifabutin.
Check for recent or prior Clostridioides difficile infection; all antibiotics can increase this risk.
Do not use rifaximin for bacterial diarrhoea with fever or bloody diarrhoea.
Absolute Contraindications: hypersensitivity to rifaximin or related rifamycins; bacterial diarrhoea with fever or bloody diarrhoea.
Suggested Patient Screening Checklist:
- Allergies: rifaximin, rifampicin, rifabutin, rifapentine.
- Current infections: any fever, bloody stool, systemic symptoms.
- Pregnancy or breastfeeding status.
- Severe liver disease (Child‑Pugh C) or hepatic encephalopathy with unstable liver function.
- History of C. difficile infection or recent broad‑spectrum antibiotic use.
Monitoring Needs:
- Review liver function tests in patients with significant hepatic disease.
- Watch for symptoms of C. difficile infection: severe, persistent or bloody diarrhoea.
- Counsel patients to report severe diarrhoea, rash or signs of hypersensitivity immediately.
Interaction With Activities (Driving, Workplace Safety Under UK Law)
Rifaximin has minimal systemic absorption and a low interaction profile.
Some patients report dizziness or fatigue that could affect driving or safety‑critical tasks.
If a person feels dizzy, drowsy or has blurred vision after taking the medicine, they should not drive or operate machinery.
Advise employees to record any treatment or side effects on workplace medical records where required.
Q&A — Can I Drive After Taking It In The UK?
Short answer: usually yes, provided you feel well.
If you experience dizziness, drowsiness or blurred vision, do not drive and follow DVLA guidance.
Report adverse effects via the MHRA Yellow Card scheme.
Usage Basics
INN, Brand Names Available In The UK
The International Nonproprietary Name (INN) is rifaximin.
International brands include Xifaxan and Normix, with tablets commonly at 200mg and 550mg strength.
Prescribers in the UK should specify rifaximin on prescriptions and check local product availability with wholesalers or community pharmacies.
Legal Classification (POM, P, GSL)
Rifaximin is a prescription‑only medicine (POM) in major markets.
In the UK it is classified as prescription‑only; prescriptions may be issued in primary care, hospital clinics or via NHS e‑prescription services.
- Bring your NHS number when collecting repeat prescriptions.
- State any prescription exemptions you qualify for when paying in England.
- Ask the pharmacist for counselling at collection and keep a written dosing plan.
Dosing Guide
Standard Regimens (NHS Guidelines)
| Indication | Adult Dose |
|---|---|
| Travellers' diarrhoea (E. coli) | 200mg orally three times a day for 3 days |
| IBS‑D (Irritable Bowel Syndrome‑Diarrhoea) | 550mg orally three times a day for 14 days |
| Hepatic encephalopathy (HE) | 550mg orally twice a day, long‑term management as directed |
Paediatric use is generally for patients aged 12 years and older for some indications; IBS‑D use is not established under 18 years.
For repeated IBS‑D courses, document symptom response and discuss repeat prescribing with the GP or gastroenterologist.
Adjustments For Comorbidities
No dose adjustment is required for renal impairment due to minimal systemic absorption.
Use with caution in severe hepatic impairment (Child‑Pugh C); monitor closely, especially in patients treated for HE.
Q&A — What If I Miss A Dose?
Take the missed dose as soon as you remember unless it is near the time for the next dose.
Do not double up doses to make up for a missed one.
If unsure, contact the pharmacist or GP for advice.
Interaction Chart
Food And Drinks (Alcohol, Tea/Coffee, Diet Habits)
Because rifaximin is minimally absorbed, clinically significant food or alcohol interactions are uncommon.
Follow the product labelling about taking with or without food.
- Stay well hydrated during diarrhoeal illness.
- Avoid excessive alcohol while recovering from diarrhoea.
- Maintain normal diet unless advised otherwise by a clinician.
Common Drug Conflicts (MHRA Yellow Card Data)
Overall, drug–drug interactions are low with rifaximin due to minimal systemic metabolism.
| Potential Interaction | Notes |
|---|---|
| Rifamycin allergy cross‑reactivity | Patients allergic to rifampicin or rifabutin may react to rifaximin; avoid if history of hypersensitivity. |
| Hepatically active drugs | Use caution combining with other hepatically active medicines in severe liver disease; monitor liver function. |
| CYP interactions | No major CYP interactions expected because systemic exposure is minimal. |
Encourage reporting of suspected interactions via the MHRA Yellow Card.
User Reports & Trends
Patients commonly report quick relief when rifaximin is used for travel‑related E. coli diarrhoea.
Many people with IBS‑D describe measurable reduction in diarrhoea frequency and improvement in quality of life during a 14‑day course.
Commonly reported side effects include nausea, bloating and headache, with occasional dizziness.
- Efficacy reports: rapid improvement for travellers' diarrhoea; partial symptom relief for IBS‑D.
- Side‑effect experiences: mild gastrointestinal upset, headache, fatigue, rare rash.
- Repeat prescription requests: frequent in patients with recurrent IBS‑D symptoms.
For clinicians and editors: use anonymised quotes only with permission; otherwise present aggregated sentiment.
SEO and E‑E‑A‑T tip: cite NHS and peer‑reviewed sources when discussing outcomes and note that forum posts are patient‑reported anecdote, not clinical evidence.
Access & Purchase Options
Boots, LloydsPharmacy, Superdrug
High‑street pharmacies dispense rifaximin on prescription and can advise on dosing and side‑effects.
Brand availability such as Xifaxan or Normix may vary by pharmacy; ask the pharmacist to order if stock is not available.
Call ahead to check stock and private pricing before a visit.
Online Pharmacies And NHS E‑Prescriptions
Prescribers can send NHS e‑prescriptions to nominated pharmacies or private prescriptions to community or online pharmacies.
Patients should only use MHRA‑registered online services and avoid unregulated overseas sites.
In our online pharmacy, xifaxanta is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
Checklist For Safe Purchase:
- Valid UK prescription (unless using a service that lawfully supplies without one).
- Pharmacy registered with the General Pharmaceutical Council or MHRA‑registered online service.
- Pharmacist counselling available before supply.
- Check batch number and expiry on packaging at receipt.
Mechanism & Pharmacology
Simplified Explanation
Rifaximin is a gut‑targeted antibiotic that binds the β‑subunit of bacterial RNA polymerase to inhibit bacterial RNA synthesis.
Low systemic absorption concentrates its activity in the intestinal lumen, making it effective against enteric E. coli and bacterial overgrowth implicated in IBS‑D.
Clinical Terms
- Non‑systemic: acts mainly in the gut rather than throughout the body.
- ATC A07AA11: classification for intestinal antiinfectives.
- Bacterial overgrowth: excess bacteria in the small intestine linked to diarrhoea and bloating.
Mechanism supports a generally low systemic adverse‑event profile but antibiotics can alter the gut microbiome and increase C. difficile risk.
Indications & Off-Label Uses
MHRA‑Approved Uses
Licensed indications internationally include travellers' diarrhoea caused by E. coli, IBS‑D and hepatic encephalopathy.
UK prescribers should consult MHRA and the BNF for local licensed indications and product SPCs.
Off‑Label Practices In NHS And Private Care
Some clinicians prescribe rifaximin off‑label for suspected small intestinal bacterial overgrowth (SIBO) or recurrent IBS‑D after other measures fail.
Document the rationale, obtain informed consent and set clear review dates for off‑label use.
Practical steps before off‑label prescribing:
- Confirm symptom pattern and consider breath testing where available.
- Discuss risks including C. difficile and antibiotic effects on gut flora.
- Set an outcome review date and monitoring plan.
Key Clinical Findings
Recent UK and EU trials between 2022 and 2025 show rifaximin provides modest but clinically meaningful improvements in IBS‑D symptoms compared with placebo.
Short‑course rifaximin is effective for travellers' diarrhoea due to non‑invasive E. coli.
Rifaximin used alongside lactulose reduces recurrence of hepatic encephalopathy in chronic management.
| Study (Year) | Population | Intervention | Primary Outcome |
|---|---|---|---|
| Randomised IBS‑D Trials (2022–2024) | Adults with IBS‑D | Rifaximin 550mg TID x14 days vs placebo | Symptom relief and reduced diarrhoea episodes; modest NNT reported |
| Travellers' Diarrhoea Studies (multiple) | Adults with E. coli travellers' diarrhoea | Rifaximin 200mg TID x3 days | Faster symptom resolution vs supportive care |
| HE Adjunct Studies | Patients with recurrent HE | Rifaximin 550mg BID plus lactulose | Lower HE recurrence rates vs lactulose alone |
For E‑E‑A‑T, cite peer‑reviewed journals such as Gut and Cochrane when using this evidence in clinical materials.
Long‑term effects on the microbiome remain an area of ongoing research and require monitoring in practice.
Alternatives Matrix
NHS Prescribing Alternatives (Comparison Table)
| Medicine | Indication | Onset | Efficacy | Safety Concerns |
|---|---|---|---|---|
| Loperamide | Symptomatic control of diarrhoea | Rapid | Good for symptom control | Not for dysentery/fever; constipation risk |
| Eluxadoline | IBS‑D (selected patients) | Moderate | Reduces diarrhoea and pain in some | Pancreatitis risk; check suitability |
| Metronidazole / Ciprofloxacin | Traveller's diarrhoea alternative | Moderate | Effective for many bacterial causes | Systemic side‑effects; use with caution |
| Neomycin | Hepatic encephalopathy alternative | Variable | Used off‑label for HE | Ototoxicity, nephrotoxicity risk if absorbed |
| Lactulose | Hepatic encephalopathy adjunct | Days | Reduces ammonia and HE episodes | GI side‑effects; requires titration |
Pros And Cons Checklist
- Loperamide — Pro: immediate symptom control. Con: not suitable with dysentery or fever.
- Eluxadoline — Pro: targeted for IBS‑D. Con: contraindicated in patients without a gallbladder or with severe constipation.
- Metronidazole/Ciprofloxacin — Pro: effective systemic coverage. Con: systemic adverse effects and resistance concerns.
- Neomycin — Pro: non‑absorbable option for HE. Con: potential toxicity if absorbed; typically hospital supervised.
Common Questions
Will It Stop My IBS Cramps?
Many patients see improvement in diarrhoea and some reduction in cramping.
Response varies between individuals and should be discussed with the prescriber to set realistic expectations.
Can Children Take It?
Use has been studied in patients aged 12 years and older for some indications.
Not established for younger children; consult paediatric guidance before use.
Does It Cause Resistance?
Rifaximin alters local gut flora; systemic resistance risk is low due to minimal absorption.
Antibiotic stewardship remains important; use only when indicated.
- When to call GP: persistent fever, bloody stools, or worsening symptoms.
- What to expect in 48–72 hours: symptomatic improvement for travellers' diarrhoea; IBS‑D response may vary up to 2 weeks.
- When to stop and seek urgent care: development of severe abdominal pain, high fever, or bloody diarrhoea.
NHS Cost & Access Comparison Table
| Provider | Typical Private Cost Band | NHS Prescription Fee (England) | Exemption Notes (Scotland/Wales/NI) | Stock Availability Note |
|---|---|---|---|---|
| Boots | Variable (higher for branded Xifaxan) | Standard NHS fee per item | Scotland, Wales and NI: prescriptions generally free | Generic rifaximin often available; branded stock varies |
| LloydsPharmacy | Variable | Standard NHS fee per item | As above | May order in if not on shelf |
| Superdrug | Variable | Standard NHS fee per item | As above | Pharmacy stock varies by branch |
| Online Pharmacies | Variable; often competitive | Depends on prescription status | As above | Check registration and MHRA status before ordering |
Checklist For Patients:
- Check entitlement to free prescriptions and bring proof if exempt.
- Ask about generic rifaximin to reduce cost.
- Request the patient information leaflet and a follow‑up plan.
Registration & Regulation
MHRA Approval Process
The MHRA regulates marketing authorisations and pharmacovigilance in the UK.
Prescribers should confirm licensed product details and SPC via MHRA or the BNF.
Since Brexit, MHRA listings are the authoritative UK source for licensing information.
NHS Prescribing Framework
Use the INN rifaximin on prescriptions where appropriate and indicate the indication on private scripts if clarity is needed.
- Check licence and formulary status before prescribing.
- Obtain informed consent and document rationale for any off‑label use.
- Report adverse events via the Yellow Card scheme and record supply in primary care records.
Storage & Handling
UK Household Storage (Cold/Damp Climate)
Store tablets at 20–25°C and protect from moisture, with permitted excursions between 15–30°C.
In humid UK homes, keep the medicine in its original blister or bottle in a dry room, not a bathroom.
Keep out of reach of children and pets.
Guidance From NHS And Pharmacists
Pharmacists should advise patients to keep medication in the original packaging and to note the expiry date.
Return unused medicine to a pharmacy for safe disposal rather than flushing down the toilet.
Patient Handout Checklist:
- Storage temperature and moisture protection.
- Missed dose instructions.
- Disposal instructions and returning unused tablets to pharmacy.
Guidelines For Proper Use
UK Pharmacist Counselling Style
Confirm the indication, review allergies and current medicines, and explain the dosing schedule clearly.
Discuss likely side effects and when to stop and seek medical help.
Document counselling in pharmacy records and provide written instructions where possible.
Counselling Checklist Template:
- Identity check and consent.
- Clear dosing instructions with duration.
- Side‑effects to expect and red flags to seek urgent care for.
- Driving and work safety advice.
- Follow‑up plan and Yellow Card reporting information.
NHS Patient Safety Advice
Reinforce antibiotic stewardship: use only as prescribed and do not share medication.
Report severe diarrhoea or rash immediately and seek urgent care for fever or bloody stools.
Discuss pregnancy and breastfeeding risks with the prescriber; use with caution in severe liver impairment and monitor.
Encourage reporting adverse events via the MHRA Yellow Card and scheduling GP review if symptoms persist beyond expected course.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | England | 5-7 days |
| Birmingham | England | 5-7 days |
| Manchester | England | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Cardiff | Wales | 5-7 days |
| Belfast | Northern Ireland | 5-7 days |
| Leeds | England | 5-9 days |
| Newcastle | England | 5-9 days |
| Nottingham | England | 5-9 days |
| Brighton | England | 5-9 days |
| Plymouth | England | 5-9 days |
| Aberdeen | Scotland | 5-9 days |
| Swansea | Wales | 5-9 days |